| Bioactivity | Tauro 6-ethlchenodeoxycholic acid-d5(sodium） is deuterium labeled Tauro-obeticholic acid. Tauro-obeticholic acid is an active metabolite of Obeticholic acid. Obeticholic acid is an orally bioavailable farnesoid-X receptor (FXR) agonist[1][2]. |
| Formula | C28H43D5NNaO6S |
| Molar Mass | 554.77 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Markham A, et al. Obeticholic Acid: First Global Approval. Drugs. 2016 Aug;76(12):1221-6. |
Tauro 6-ethlchenodeoxycholic acid-d5(sodium）
CAS: F: C28H43D5NNaO6S W: 554.77
Tauro 6-ethlchenodeoxycholic acid-d5(sodium） is deuterium labeled Tauro-obeticholic acid. Tauro-obeticholic acid is an
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.